Cardiac biomarker testing market to reach $10.21 billion by 2032, growing at 9.47% CAGR

From GlobeNewswire: 2025-01-16 08:08:00

The Cardiac Biomarker Testing Market was valued at USD 4.53 billion in 2023 and is projected to reach USD 10.21 billion by 2032, growing at a CAGR of 9.47%. The rising incidence of cardiovascular diseases is driving demand for diagnostic tools like troponin, BNP, and NT-proBNP, crucial for detecting heart conditions.

Technological advancements in diagnostic tools and a preference for point-of-care testing are fueling the growth of the Cardiac Biomarker Testing market. Reagents and kits dominate the market, with troponin I and T biomarkers holding a 40% share due to their sensitivity in diagnosing heart attacks.

Major players in the market include F. Hoffmann-La Roche AG, Abbott Laboratories, and Siemens Healthineers AG, among others. North America leads in market share at 40%, followed by Europe and the Asia Pacific region, which is expected to see the highest growth rate due to increasing healthcare access and expenditures. The Cardiac Biomarkers Testing Market is set for substantial growth due to technological advancements and increased demand for accurate diagnostic tests, driven by the region’s need for cost-effective solutions and point-of-care testing. With a focus on preventive healthcare and personalized medicine, the market is projected to reach new heights by 2032.

Key points in the Cardiac Biomarker Testing Market Analysis & Outlook Report 2024-2032 include incidence and prevalence of cardiac diseases, diagnostic trends, test volume, healthcare spending, technological advancements, regulatory landscape, and competitive landscape. The report also covers product types, biomarker types, diseases, end users, regional analysis, company profiles, use cases, and best practices.

For more detailed information and access to the complete report details of the Cardiac Biomarker Testing Market Analysis & Outlook 2024-2032, visit the SNS Insider website. SNS Insider is a leading market research and consulting agency providing clients with the knowledge they need to navigate changing circumstances, offering current market data, consumer insights, and opinions through various research techniques globally.



Read more at GlobeNewswire: Cardiac Biomarker Testing Market Size to Hit USD 10.21